BUSINESS

• DMD Gene Therapy Elevidys Hits Japan Market at Record Price
  February 20, 2026

• Bayer Eyes Kerendia as Standard Therapy for CKM Syndrome
  February 20, 2026

• Enhertu Accepted for EU Review in Post-Neoadjuvant HER2 Breast Cancer
  February 20, 2026

• SymBio Receives Grant for Antiviral Brincidofovir
  February 20, 2026

• Over 40% of Breast Surgeons Largely Unaware of Clinical Trials: Survey
  February 20, 2026

• Asahi Kasei’s Flagship Teribone to Undergo US Feasibility Review by MAIA
  February 20, 2026

• Asahi Kasei, Alchemedicine Begin PI Trial of CKD Drug
  February 20, 2026

• Japan IP High Court Upholds Invalidation of Key Trazenta Dosage Patent
  February 19, 2026

• ONODERA GT Pharma Targets 2026 Filings for Two Gene Therapies
  February 19, 2026

• Sumitomo Pharma Sees iPSC Therapy as Potential US$1 Billion Global Product
  February 18, 2026

• AstraZeneca Launches Japan Registry Study of Imfinzi in Limited-Stage SCLC
  February 18, 2026

• Asahi Kasei Gets Global Rights to Alchemedicine’s Lead Compounds
  February 18, 2026

• Teijin, ASKA Hook Up on Gynecology Drug Discovery
  February 18, 2026

• Fycompa Generics Approved despite Extended Patent, Hydrate Switch in Play?
  February 17, 2026

• Espha Snags Bilanoa AG in Final Pre-Rule Approval Window
  February 17, 2026

• Rakuten to Launch Japan PI of RM-0256 Photoimmunotherapy in April-June
  February 17, 2026

• Kidswell, Treehill to Form US Firm for Cell Therapy Development
  February 17, 2026

• Ono’s Velexbru Accepted for FDA Review in PCNSL
  February 17, 2026

• Celltrion Sets April 28 Launch Date for Japan’s 1st Actemra Biosimilar
  February 17, 2026

• Nxera Cuts Executive Pay as Losses Widen
  February 16, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »